Compound

GSK839

GlaxoSmithKline
Names
Tetrazole benzene sulfonamide
Chemical Class:
Tetrazole
Name of Target:
Tryptophan Synthase (TrpAB)
Description

Description: GSK839 is a preclinical candidate for Tuberculosis treatment that was identified as result of a Wellcome Trust sponsored programme. GSK839 is a new chemical class that inhibits M. tuberculosis Tryptophan Synthase (TrpAB) in a selective manner. GLP tox studies are being planned for 2020.

Developer Associations: GlaxoSmithKline

Chemical Class: Tetrazole

Name of Target: Tryptophan Synthase (TrpAB)

Developer Associations